Fig. 9From: Caloric restriction and metformin selectively improved LKB1-mutated NSCLC tumor response to chemo- and chemo-immunotherapyGraph of body weight of mice bearing K and KL tumours: Body weight of KRASG12D (A) and KRASG12D/LKB1del (B) mice used in Fig. 10. Untreated mice (CTRL) were compared to mice treated with DDP or DDP/MET/CR. The treatment schedule was well-tolerated, as the body weight lost during the fasting period was regain within 24 h. Intramuscular inoculation of KL cells, induced a massive weight loss in immunocompetent miceBack to article page